The Pharma Industry - Can there be certainty in uncertain times?

An Expert Panel Discussion

We are delighted to invite you to an expert panel discussion on the unique challenges for the international pharma and biotech sector hosted by FrankfurtRheinMain. The Frankfurt region
is known for being the financial centre of the eurozone and is also home to one of the world’s largest research and life science manufacturing clusters.

With no official agreement in sight as to how the UK and the EU will do business after Brexit, this open and interactive panel discussion hosted by FrankfurtRheinMain, one of Germany’s
most dynamic business regions, will explore new solutions to maintain the seamless and positive trading landscape across Europe.

Prof. Dr. Jochen Maas, General Manager R&D, Sanofi-Aventis Deutschland GmbH, will deliver the keynote speech followed by an international expert panel discussion.

Tuesday, 10 September 2019
6.00 pm to 8.00 pm (Registration 5.30 pm)
St. Pancras Renaissance Hotel
Euston Rd, London NW1 2AR

To an industry that prides itself on international cooperation, the post-Brexit environment poses specific challenges, which our team of experts will explore in this collaborative forum. From regulatory issues and certification through to recruiting and retaining highly skilled staff, all companies trading in or with the UK will be affected by potential trade barriers.


5.30 pm Registration

6.00 pm Welcome remarks
Eric Menges, President and CEO, FrankfurtRheinMain GmbH International Marketing of the Region

Keynote speech
Prof. Dr. Jochen Maas, General Manager R&D, Sanofi-Aventis Deutschland GmbH

6.15 pm Panel discussion

Prof. Dr. Michael J. Parnham, FBPhS, Head of Preclinical Research at Fraunhofer IME-TMP

Dr. Christian Garbe, Managing Director, FiZ Frankfurt Biotechnology Innovation Center
Prof. Dr. Bertram Häussler, Chairman of the Board of Management, IGES Institute, one of Germany’s largest healthcare research institutes
Dr. Paul Ingram, Global Director, Strategic Development and Innovation, Clinical Supply Services, Catalent Pharma Solutions
Dr. Elmar Kroth, Managing Director Scientific Affairs, German Medicines Manufacturers’ Association
Prof. Dr. Jochen Maas, General Manager R&D, Sanofi-Aventis Deutschland GmbH

Q & A

7.15 pm Networking reception & fingerfood & drinks

This forum is designed to provoke a lively discussion and debate as well as provide information and guidance. The panel discussion will be followed by a networking reception and fingerfood & drinks.
We look forward to meeting you on 10 September. if you would like to attend this event, simply send an email to Ms Niina Hagström at your earliest convenience to register. The event is free to attend, but places are limited and will be allocated on a first-come, first-served basis.